FDA Approves New COVID-19 Vaccines

The U.S. Food and Drug Administration (FDA) on Aug. 22 approved new COVID-19 vaccines from Moderna and Pfizer-BioNTech. The shots, based on messenger ribonucleic acid technology (mRNA), target the KP.2 strain. “These updated vaccines meet the agency’s rigorous, scientific standards for safety, effectiveness, and manufacturing quality,” Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said in a statement. “Given waning immunity of the population from previous exposure to the virus and from prior vaccination, we strongly encourage those who are eligible to consider receiving an updated COVID-19 vaccine to provide better protection against currently circulating variants.”...